Premium
Differential expression of TOX by skin‐infiltrating T cells in Sézary syndrome and erythrodermic dermatitis
Author(s) -
Boonk Stephanie E.,
Çetinözman Fatma,
Vermeer Maarten H.,
Jansen Patty M.,
Willemze Rein
Publication year - 2015
Publication title -
journal of cutaneous pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 75
eISSN - 1600-0560
pISSN - 0303-6987
DOI - 10.1111/cup.12490
Subject(s) - staining , immunohistochemistry , pathology , eczematous dermatitis , differential diagnosis , medicine , dermatology
Background The histopathologic differentiation between Sézary syndrome ( SS ) and erythrodermic dermatitis may be extremely difficult. In this immunohistochemical study, it was investigated if thymocyte selection‐associated high mobility group box protein ( TOX ) and C‐MYC can be used as additional diagnostic markers to differentiate between SS and erythrodermic dermatitis. Method Paraffin‐embedded skin biopsies from 15 SS patients and 17 erythrodermic dermatitis patients were stained and scored for TOX or C‐MYC expression. Results Strong nuclear staining for TOX in more than 50% of skin‐infiltrating T cells was observed in 13 of 15 (87%) SS cases, whereas erythrodermic dermatitis cases showed weak nuclear staining in 11–50% (median: 25%) of the T cells; strong nuclear staining as found in SS was never observed in erythrodermic dermatitis. No significant differences in C‐MYC expression between SS and erythrodermic dermatitis were found. In most patients of both groups, percentages of C‐MYC positive‐cells varied between less than 10 and 25% of skin‐infiltrating T cells. Conclusion Our results suggest that strong expression of TOX in more than 50% of skin‐infiltrating T cells in erythrodermic skin is a useful marker in the differentiation between SS and erythrodermic dermatitis, whereas staining for C‐MYC does not contribute to differential diagnosis.